Ask HopeStage to review this study with me
Study ID: NCT01663974. We help you review the study, but cannot decide medical eligibility.
TerminatedNCT01663974
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolarity
This study has public registry information. It focuses on bipolarity and currently lists study information in France.
Bipolarity, Depression, ...OtherOver 18 Years
Key information made simple
What is this study testing?
This study is testing whether Sub-syndromal Symptoms After Acute Depressive Episode may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive Sub-syndromal Symptoms After Acute Depressive Episode, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in France.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
The official record suggests in-person participation through a research setting, with sites including Research Site in Aix-en-Provence, Research Site in Ajaccio, and Research Site in Altkirch. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include pregnancy or breastfeeding and active substance or alcohol problems that could affect the results. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateApril 2013
- Recruitment status
- Terminated
- Estimated enrollment
- Not clearly listed
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- Over 18 Years
- Official registry ID
- NCT01663974
- Official title
- Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolarity
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT01663974. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may help improve understanding of your condition.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in France.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring observational follow-up for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Why is the study type not clearly categorized?
The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.
Do I need to want to stop or reduce tobacco use to participate?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What risks or points should I check?
The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by AstraZeneca, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is not currently recruiting. Check the official registry for the reason and latest status.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT02765880
Time,Self and Spontaneous Mental Activities in people with Psychotic Disorders
This study has public registry information. It focuses on schizophrenia and currently lists study information in France.
TerminatedNCT06033326
Validation of the French Version of the Lithium Knowledge Test (LKT)
This study has public registry information. It focuses on bipolarity and currently lists study information in France.
TerminatedNCT05518149
Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)
This study has public registry information in the United States, in Australia, in France, .... It is testing aticaprant for depression.